Continue reading this on our app for a better experience

Open in App
Floating Button

SGX IPOs to see year end pick up with Sheffield Green, Winking Studios lodging prospectuses

The Edge Singapore
The Edge Singapore • 2 min read
SGX IPOs to see year end pick up with Sheffield Green, Winking Studios lodging prospectuses
Photo: Albert Chua
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

New listing activity in Singapore is seemingly picking up after a near-year-long drought, with two companies filing their preliminary prospectuses for their respective Catalist listings.

Sheffield Green, whose listing is managed by Evolve Capital, provides workers for the engineering industries, has filed on Sept 28.

The company, led and controlled by chairman and executive director Kee Boo Chye, reported earnings of US$2.46 million for FY2023 ended March, versus a loss of US$975 incurred in the financial period ended March 31, 2022.

Revenue in the same period increased from US$4.7 million to US$19 million.

Sheffield Green's business is to provide manpower ranging from technical personnel and offshore crew.

The clients span from the onshore wind, offshore wind, solar and green hydrogen industry segments.

See also: India’s NTPC Green jumps in trading debut on demand for renewables

With funds to be raised from the planned listing, Sheffield Green plans to further grow its business in new markets. It is exploring acquisitions as well.

Separately, Winking Studios, which helps create art used in games and develop games, has also filed its preliminary prospectus on the same day. This proposed issue is managed by PrimePartners Corporate Finance and will not have a public tranche.

The company, with operations largely in China and Taiwan, says it is one of the largest game art-sourcing studios in Asia and the world.

See also: Mr DIY Indonesian business plan IPO to raise up to $399 mil

Winking Studios is led by executive chairman and CEO Johnny Jan.

Between FY2021 and FY2022, the company's revenue increased from US$23.7 million to US$24.5 million. However, earnings dropped from US$3.1 million to US$1 million because of lower margins.

Additional new listings besides these two are expected soon. Earlier this month, Advanced MedTech, a medical equipment company chaired by former Singapore Economic Development Board (EDB) chairman Philip Yeo, is reportedly planning an SGX listing to raise up to US$300 million, which will give it a valuation of around US$1 billion.

 

 

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.